Ranked #7,137 of 8,699 institutional investors
BML Capital Management, LLC
Zionsville, IN
$147M
US stock portfolio at live prices · today −$1.5M (−1.04%)
Market closed. Prices as of Nov 20, 8:11 AM ET
- Value at quarter end (Q3 2026)
- $186M
- Change from Q2 2026
- +$11.3M (+6.45%)
- Positions
- 17 · 3 new, 0 sold out
- Filed
- Nov 6, 2026
Not counted in the ranking: put options on $1.2M. $4.3M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesACRS 26.0%AVIR 18.0%KHC 8.03%ENGN 7.96%PMVP 6.51%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | 10,955,000 | $38.3M | 26.0% | Reduced −9% |
| AVIR Atea Pharmaceuticals, Inc. | 6,753,658 | $26.5M | 18.0% | Reduced −3% |
| KHC The Kraft Heinz Company | 475,000 | $11.8M | 8.03% | Added +2% |
| ENGN enGene Therapeutics Inc. | 6,669,908 | $11.7M | 7.96% | Unchanged |
| PMVP PMV Pharmaceuticals, Inc. | 7,330,000 | $9.6M | 6.51% | Added +38% |
| TLYS Tilly's, Inc. | 2,150,000 | $8.8M | 5.95% | Unchanged |
| KMX CarMax, Inc. | 172,500 | $8.6M | 5.85% | Unchanged |
| OM Outset Medical, Inc. | 2,519,701 | $7.3M | 4.97% | Unchanged |
| TGT Target Corporation | 37,500 | $6.3M | 4.26% | Unchanged |
| TIL Instil Bio, Inc. | 645,600 | $3.6M | 2.43% | Unchanged |
| ORMP Oramed Pharmaceuticals Inc. | 884,392 | $3.3M | 2.21% | Added +2% |
| SEER Seer, Inc. | 2,186,587 | $3.0M | 2.05% | New |
| JANX Janux Therapeutics, Inc. | 151,126 | $1.6M | 1.05% | Reduced −2% |
| PLRX Pliant Therapeutics, Inc. | 1,546,137 | $959K | 0.65% | Unchanged |
| LENZ LENZ Therapeutics, Inc. | 283,114 | $946K | 0.64% | New |
| IMA ImageneBio, Inc. | 200,730 | $799K | 0.54% | Unchanged |
| KPTIQ Karyopharm Therapeutics Inc. | 71,839 | $2K | <0.1% | New |